We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+23.64%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$4.85B
AUM Growth
+$776M
Cap. Flow
-$59.3M
Cap. Flow %
-1.22%
Top 10 Hldgs %
15.77%
Holding
1,541
New
35
Increased
499
Reduced
518
Closed
468

Sector Composition

Rank Sector Weight
1 Technology 20.53%
2 Healthcare 14.25%
3 Financials 13.94%
4 Consumer Discretionary 9.21%
5 Communication Services 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BERY
151
DELISTED
Berry Global Group, Inc.
BERY
$8.06M 0.17%
197,978
+185,618
+1,502% +$6.97M
EFA icon
152
iShares MSCI EAFE ETF
EFA
$80.2B
$8.05M 0.17%
132,294
-273,523
-67% -$15.8M
WBA
153
DELISTED
Walgreens Boots Alliance
WBA
$8.04M 0.17%
189,727
+909
+0.5% +$38.6K
SPLK
154
DELISTED
Splunk Inc
SPLK
$8.04M 0.17%
40,470
-676
-2% -$107K
APD icon
155
Air Products & Chemicals
APD
$67.6B
$8M 0.17%
33,129
-1,606
-5% -$367K
FIVE icon
156
Five Below
FIVE
$13.5B
$7.86M 0.16%
73,478
+1,179
+2% +$111K
RBA icon
157
RB Global
RBA
$17.5B
$7.85M 0.16%
192,111
+11,921
+7% +$488K
VRTX icon
158
Vertex Pharmaceuticals
VRTX
$126B
$7.59M 0.16%
26,165
-5,165
-16% -$1.4M
VAR
159
DELISTED
Varian Medical Systems, Inc.
VAR
$7.59M 0.16%
61,922
+27,612
+80% +$3.2M
FDX icon
160
FedEx
FDX
$75.4B
$7.58M 0.16%
54,087
+10,560
+24% +$1.33M
DOW icon
161
Dow Inc
DOW
$21.2B
$7.55M 0.16%
185,123
-1,571
-0.8% -$57.5K
MAS icon
162
Masco
MAS
$15.3B
$7.45M 0.15%
148,366
-29,158
-16% -$1.26M
AMED
163
DELISTED
Amedisys
AMED
$7.37M 0.15%
37,139
+2,540
+7% +$474K
TJX icon
164
TJX Companies
TJX
$178B
$7.33M 0.15%
145,018
-21,994
-13% -$1.1M
DXCM icon
165
DexCom
DXCM
$32B
$7.28M 0.15%
71,840
+600
+0.8% +$53.7K
SYK icon
166
Stryker
SYK
$130B
$7.27M 0.15%
40,344
+4,291
+12% +$792K
DUK icon
167
Duke Energy
DUK
$97.3B
$7.26M 0.15%
90,892
+17,266
+23% +$1.46M
COR icon
168
Cencora
COR
$61.2B
$7.25M 0.15%
71,991
-28,015
-28% -$2.58M
ROL icon
169
Rollins
ROL
$18.2B
$7.11M 0.15%
251,699
+19,010
+8% +$509K
KR icon
170
Kroger
KR
$34.8B
$6.84M 0.14%
201,962
-34,479
-15% -$1.12M
IBM icon
171
IBM
IBM
$224B
$6.82M 0.14%
59,078
-8,060
-12% -$936K
IFF icon
172
International Flavors & Fragrances
IFF
$21.9B
$6.79M 0.14%
55,426
+6,335
+13% +$801K
GPK icon
173
Graphic Packaging
GPK
$3.58B
$6.76M 0.14%
482,901
-12,926
-3% -$174K
GSK icon
174
GSK
GSK
$106B
$6.72M 0.14%
131,820
-10,045
-7% -$515K
IWF icon
175
iShares Russell 1000 Growth ETF
IWF
$128B
$6.72M 0.14%
139,972
-8,152
-6% -$359K

Similar funds

Oppenheimer Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Oppenheimer Asset Management held 1,541 positions worth $4.85B, up 19% from $4.07B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Oppenheimer Asset Management's Q2 2020 filing shows 35 new, 499 increased, 518 reduced and 468 closed positions. Its largest new stake was iShares MSCI EAFE Growth ETF: 69,225 shares worth $5.75M. The largest sale was Goldman Sachs Access Treasury 0-1 Year ETF, an estimated $42.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer Asset Management's largest Q2 2020 buy was iShares MSCI EAFE Growth ETF: 69,225 shares worth $5.75M.
  • Oppenheimer Asset Management added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q2 2020, an estimated $14.6M increase.
  • Oppenheimer Asset Management's biggest Q2 2020 reduction was iShares MSCI EAFE ETF, cutting an estimated $15.8M.
  • Oppenheimer Asset Management fully exited Goldman Sachs Access Treasury 0-1 Year ETF in Q2 2020, selling an estimated $42.4M.
  • Oppenheimer Asset Management's ten largest holdings make up 16% of its $4.85B portfolio in Q2 2020.
  • Oppenheimer Asset Management opened 35 new positions and closed 468 in Q2 2020.
  • Oppenheimer Asset Management's portfolio value rose 19% quarter-over-quarter to $4.85B.

Based on Oppenheimer Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.